Mountain View, CA, United States of America

David C Casal


Average Co-Inventor Count = 2.3

ph-index = 3

Forward Citations = 79(Granted Patents)


Location History:

  • Mountain View, CA (US) (1995 - 1996)
  • Foster City, CA (US) (1997)

Company Filing History:


Years Active: 1995-1997

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by David C. Casal in Preventing Premature Delivery

Introduction

David C. Casal is an accomplished inventor based in Mountain View, California. He has made significant contributions to the field of obstetrics through his innovative patents aimed at preventing premature delivery. With a total of three patents to his name, his work has the potential to improve outcomes for pregnant women at risk of preterm labor.

Latest Patents

One of Casal's latest patents focuses on the use of urinastatin-like compounds to prevent premature delivery. This invention provides a method for diagnosing and treating pregnant females who are at risk for impending preterm delivery. The method involves testing for imminent preterm delivery with a sensitivity and specificity of at least 80%. If the test indicates a risk, a combination of a tocolytic agent, urinastatin-like compounds, and antibiotics is administered.

Another significant patent by Casal is a screening method for identifying women at increased risk for imminent preterm delivery. This method offers an early biochemical indication of risk by analyzing cervicovaginal secretion samples from pregnant patients after week 12 of gestation. An elevated level of a specific inflammatory protein in the sample indicates an increased risk of delivery, allowing for timely intervention.

Career Highlights

David C. Casal is currently associated with Adeza Biomedical Corporation, where he continues to work on innovative solutions in women's health. His expertise and dedication to research have positioned him as a key figure in the development of methods to enhance maternal and fetal health.

Collaborations

Some of his notable coworkers include Andrew E. Senyei and Toshihiko Terao, who have collaborated with him on various projects aimed at advancing medical technology in obstetrics.

Conclusion

David C. Casal's contributions to the field of obstetrics through his innovative patents demonstrate his commitment to improving maternal and fetal health. His work has the potential to significantly impact the way preterm delivery is diagnosed and managed.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…